TYRP1 and cervical squamous intraepithelial neoplasia: Overall, the 56% survival rate in the third challenge, in the absence of anti-Tyrp1, and the partial responses observed in mice that grew tumors suggest a durable immunological response that results from encountering and clearing CIN tumors, at least in the context of CD47 disruption.